ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 44 filers reported holding ELIEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $494,000 | – | 47,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,938,263 | $5,097,632 | 4.68% |
| RA Capital Management | 13,150,849 | $34,586,733 | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 121,110 | $318,519 | 0.10% |
| Atom Investors LP | 78,886 | $207,470 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | $2,134,718 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $145,789 | 0.00% |
| Chicago Partners Investment Group LLC | 12,806 | $32,785 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,704 | $78,122 | 0.00% |
| NORTHERN TRUST CORP | 11,182 | $29,409 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |